Description of a novel adhesin of Mycobacterium avium subsp. paratuberculosis by Viale, Mariana Noelia et al.
Research Article
Description of a Novel Adhesin of Mycobacterium avium
Subsp. paratuberculosis
Mariana Noelia Viale,1 Gabriela Echeverria-Valencia,1 Pablo Romasanta,2
María Laura Mon,1 Marisa Fernandez,2 Emilio Malchiodi,2 María Isabel Romano,1
Andrea Karina Gioffré,1 and María de la Paz Santangelo1
1 Instituto de Biotecnologı´a, Instituto Nacional de Tecnologı´a Agropecuaria, 1686 Hurlingham, Buenos Aires, Argentina
2 Instituto de Estudios de la Inmunidad Humoral (IDEHU), Facultad de Farmacia y Bioquı´mica, Universidad de Buenos Aires,
1113 Ciudad Auto´noma de Buenos Aires, Argentina
Correspondence should be addressed to Mar´ıa de la Paz Santangelo; santangelo.maria@inta.gob.ar
Received 7 March 2014; Accepted 29 June 2014; Published 22 July 2014
Academic Editor: Armando Acosta
Copyright © 2014 Mariana Noelia Viale et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
The binding and ingestion ofMycobacterium avium subsp. paratuberculosis (MAP) by host cells are fibronectin (FN) dependent. In
several species of mycobacteria, a specific family of proteins allows the attachment and internalization of these bacteria by epithelial
cells through interactionwith FN.Thus, the identification of adhesionmolecules is essential to understand the pathogenesis ofMAP.
The aim of this study was to identify and characterize FN binding cell wall proteins of MAP. We searched for conserved adhesins
within a large panel of surface immunogenic proteins of MAP and investigated a possible interaction with FN. For this purpose, a
cell wall protein fraction was obtained and resolved by 2D electrophoresis. The immunoreactive spots were identified by MALDI-
TOF MS and a homology search was performed. We selected elongation factor Tu (EF-Tu) as candidate for further studies. We
demonstrated the FN-binding capability of EF-Tu using a ligand blot assay and also confirmed the interaction with FN in a dose-
dependent manner by ELISA. The dissociation constant of EF-Tu was determined by surface plasmon resonance and displayed
values within the 𝜇M range. These data support the hypothesis that this protein could be involved in the interaction of MAP with
epithelial cells through FN binding.
1. Introduction
Paratuberculosis (PTB) is a chronic granulomatous enteri-
tis of domestic and wild ruminants. This disease involves
extensive mycobacterial shedding, which accounts for the
high contagiousness, and ends with fatal enteritis. Decreases
in weight, milk production, and fertility produce severe
economic loss [1]. The etiological agent of PTB is Mycobac-
terium avium subsp. paratuberculosis (MAP).MAP enters the
intestinal tissue through M cells present in the dome epithe-
lium covering the continuous Peyer’s patches in the distal
ileum [2, 3]. Initially, the pathogen interacts with proteins
of the extracellular matrix (ECM), which function as ligands
for bacterial adhesion. Fibronectin (FN) binding is required
for attachment and internalization of MAP by the epithelial
cells and 𝛽1 integrins have been identified as the host cell
receptors for FN-opsonized mycobacteria in vitro and in vivo
[4]. M cells have the distinctive characteristic of displaying
𝛽1 integrins on their luminal face at high density; therefore,
the presence of these integrins on M cells may explain why
these cells are the entry of the bacteria. The interaction
between MAP and FN is explained by the presence of the
FN-binding proteins called adhesins. Different adhesins from
several pathogens were identified as virulence factors [5–
9]. Adhesins may also induce strong protective immunity
in the host and, thus, remain attractive vaccine targets. For
instance a 27-kDa outer membrane protein from Salmonella
typhi binds to laminin and induces a strong protective
antibody response in animal models and humans [10]. In
addition, the antigen 85 complex (Ag85)was the first family of
mycobacterial proteins to be identified as having FN-binding
capability. Members of the Ag85 complex were described as
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a mycobacterial adhesins firstly in M. tuberculosis [11] and
then in several mycobacterial species [12–15]. The members
of this complex are found within the outer envelope and
culture supernatants of mycobacteria and are immunodom-
inant antigens [16, 17]. Furthermore, these proteins possess
mycolyltransferase activity and catalyze the synthesis of the
most abundant glycolipid of the mycobacterial cell wall,
trehalose 6,6-dimycolate (TDM) [18]. Another important
adhesin described in mycobacteria is the fibronectin attach-
ment protein (FAP). FAP is a member of a family of FN-
binding proteins present in several species of mycobacteria
that mediate the attachment and internalization of these
bacteria by epithelial cells in vitro [19–23].This protein is also
called APA (for alanine-proline-rich antigen) and is encoded
by a gene annotated as MAP1569 in the MAP K-10 strain.
Although theMAP-APA is not an immunodominant antigen,
it activates dendritic cells and induces aTh1 polarization [24].
Furthermore, MAP-infected cattle showed a strong humoral
response to recombinant APA assayed by Western blot and
ELISA [7]. In a previous study conducted by our group,
APA was detected mainly in the culture supernatant filtrates,
demonstrating that this protein is predominantly secreted
[7]. Other cell wall proteins thus could interact with FN to
facilitate complex formation and, in this way, allow adherence
to epithelial cells.
With all this in mind, we hypothesized that molecules
with similar structure, even those from nonrelated microor-
ganisms, could have conserved adhesin functions. In the
present study, we searched for conserved adhesins within a
large panel of surface immunogenic proteins of MAP and
investigated a possible interaction with FN. By using the
ligand blot assay (LBA), we confirmed the binding properties
of a protein previously described in other bacteria and iden-
tified a novel surface component with FN-binding activity in
MAP.The protein-protein interactions revealed by LBA were
confirmed by ELISA binding assays and surface plasmon
resonance (SPR) in order to determine the dissociation
constant (KD).
2. Materials and Methods
2.1. Bacterial Strains and Culture Media. All cloning steps
were performed in Escherichia coliDH5𝛼. E. coli BL21(kDE3)
was used for recombinant protein production. E. coli was
grown in Luria Bertani (LB) broth or on LB agar. When
necessary, ampicillin was added to the medium at a concen-
tration of 100 𝜇g/mL. MAP was grown in Middlebrook 7H9
medium (Difco Laboratories, USA), 0.05% Tween 80, 0.5%
glycerol, AD (0.5%bovine serumalbumin, 0.2%glucose), and
mycobactin (2 𝜇g/mL).
2.2. Preparation of Cell Wall Protein Fraction of MAP. MAP
cultures were harvested at midlog phase, centrifuged at
14,000×g for 20min at room temperature and washed twice
with phosphate buffered saline (PBS). Cell pellets were
resuspended in lysis buffer (PBS, 1mM EDTA) with 1mM
phenylmethanesulfonyl fluoride (PMSF), an inhibitor of ser-
ine proteases, and then this suspension was probe sonicated
in an ice bath for 15min with pulses of 1min on, 1min off
in a Branson Sonifier S250. Cell wall proteins were obtained
as previously described by Hirschfield and collaborators [25].
Briefly, the sonic extract was centrifuged at 27,000×g for
20min, and the resulting cell wall containing pellet was
subjected to 2% sodium dodecyl sulfate (SDS) extraction
for 2 h at 50∘C. The SDS extraction was repeated twice. The
protein concentration in the cell wall (CW) fraction was
evaluated with Kit 2D Quant (GE Healthcare).
2.3. Two-Dimensional-SDS Polyacrylamide Gel Electrophore-
sis (2D-SDS-PAGE). For 2D analysis, CW fractions were
first desalted performing a gel filtration step (Sephadex G25
column). Proteins were precipitated with cold acetone and
resuspended in a reswelling buffer (8M urea, 2% CHAPS,
0.5% IPG buffer pH 4–7, 20mM DTT, and 0.004% bro-
mophenol blue). 2D-SDS-PAGE was performed as described
by Xolalpa and collaborators [26]. The gels were transferred
onto a nitrocellulose membrane (Hybond-ECL GE Health-
care) and the membranes were subjected to Western blot.
The sera from 5 positive animals were pooled and diluted
to 1 : 100 to detect immunogenic proteins from the CW
fraction. The immunoreactive spots were manually excised
from a replicate Coomassie blue stained gel and sent to
the Mass Spectrometry Center for Biological and Chemical
Analysis (CEQUIBIEM) at the School of Exact and Natural
Sciences, University of Buenos Aires. The mass spectrometry
platform used is made up of UV-MALDI-TOF/TOFUltraflex
II (Bruker Daltonics) and the software Mascot was used
to identify proteins from peptide sequence databases. The
protein score was calculated as −10 ∗ Log(𝑃), where 𝑃 is the
probability in which the observedmatch was a random event.
Protein scores greater than 69 are significant (𝑃 < 0.05).
The proteins identified by MALDI-TOF MS were sub-
jected to bioinformatic analysis including similarity searches
with proteins with FN-binding domains. Sequence similarity
searches were performed by BlastP (http://blast.ncbi.nlm.nih
.gov/Blast.cgi).
2.4. RecombinantMAP-EF-Tu: Cloning andExpressionAssays.
DNA from MAP was purified by the CTAB method as
described previously by van Embden and collaborators [27].
PCR amplification was performed to amplify the complete
open reading frame of EF-Tu using the forward primer eftu-
fw ggatccgcgaaggcgaagttcgag (BamHI site) and the reverse
primer eftu-rev aagcttctacttgatgatcttgac (HindIII site). The
amplified 1,190 bp fragment was cloned into pGEM-T vec-
tor (Promega) and directionally subcloned into pRSET-A
(Invitrogen). Protein expression was induced with 1mM
isopropyl 𝛽-D-1-thiogalactopyranoside (IPTG). The protein
was expressed as insoluble inclusion bodies and therefore
purified using a ProBondNi-NTAResin column (Invitrogen)
under denaturing conditions with 8M urea. After purifica-
tion, EF-Tu was refolded by gradually removing the urea
using a refolding buffer (Tris 50mM pH 8, Arg-HCl, EDTA,
GSH 3mM, GSSG 0.3mM, and PMSF 1mM). Protein quan-
tification was performed using BCA protein assay (Pierce)
following the manufacturer’s recommendations.
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2.5. Western Blot. Proteins were fractionated on 12% SDS-
PAGE, according to Laemmli procedure [28], and then
stained with 0.25% Coomassie Brilliant Blue R250 (Sigma)
or transferred onto nitrocellulose membranes (Hybond-ECL
GEHealthcare). EF-Tuwas assayed byWestern blotting using
1 : 3,000 dilution anti-His (GE Healthcare) as primary anti-
body and an alkaline phosphatase-conjugated anti-mouse
IgG (Sigma) as secondary antibody (1 : 3,000 dilution). A
colorimetric detection was performed using BCIP/NBT (5-
bromo-4-chloro-3-indolylphosphate/nitroblue tetrazolium)
Color Development (Promega), according to the manufac-
turer’s instructions.
2.6. Ligand Blot Assay (LBA). Five 𝜇g of the purified recom-
binant proteins was electrophoresed in 12% SDS-PAGE gels
and transferred onto nitrocellulose membranes (Hybond-
ECL, GE Healthcare). Ag85 [15] and AhpC were used as
positive and negative controls, respectively. The membranes
were blocked with 5% BSA in PBS buffer for 1 h at room
temperature and incubated with 20 𝜇g/mL of FN for 24 hs
at 4∘C. The membranes were then washed three times with
PBS and incubated with anti-FN in PBS-BSA 5% (1 : 100) for
2 h at room temperature, followed by a final incubation with
anti-Mouse IgG alkaline phosphatase antibody (1 : 30,000)
for 1 h at room temperature. The membranes were washed
and the colorimetric detection of the bound bait protein was
performed.
2.7. Dose-Response Curves. The 96-well plates (Polysorp
Nunc) were coated with 1 𝜇g of EF-Tu in 200𝜇L carbonate
buffer pH 9.5 at 4∘C and incubated overnight. AhpC was
included as a negative control. Plates were then blocked
and increasing concentrations of FN (0, 1, 10, 20, 50, and
100 𝜇g/mL) were added in a final volume of 200 𝜇L. Protein
binding was assessed with hyperimmune anti-FN serum at
the dilution of 1 : 100 followed by incubation with HRP-
conjugated anti-mouse IgG (Sigma) (1 : 500). Both incu-
bations were performed at 37∘C for 1 h. The wells were
washed three times, and the colorimetric detection was
performed using 280𝜇L of developing solution 2,2󸀠-azino-
bis3-ethylbenzothiazoline-6-sulphonic acid (ABTS) at a con-
centration of 10 𝜇g/mL (Sigma) and 12 𝜇L of H
2
O
2
30%
in 10mL of 0.1M citrate phosphate buffer at pH 5. The
absorbance at 405 nm was determined in a microplate reader
Multiskan Spectrum (Thermo Scientific).
2.8. Surface Plasmon Resonance (SPR). Protein-protein inter-
actions were assessed by SPR [29], using a BIAcoreT100
system (GE Healthcare). Briefly, FN was covalently immobi-
lized on the BIAcore carboxymethylated dextran matrix −5
sensor chip (GE Healthcare) according to the manufacturer’s
instructions. Protein solution of EF-Tu (0, 0.312, 0.625, 1.25,
2.5, 5.0, and 10.0 𝜇M) in 10mMHEPES, 150mMNaCl, 3mM
EDTA, 0.005% surfactant P20, pH 7.4 was injected over
immobilized FN at a flow rate of 30 𝜇L/min for 1min at
25∘C.Thedissociationwas carried outwith PBS-Tween 0.05%
or HBS-P20. Surfaces were regenerated by applying pulses
of 10mM HCl. The KD was determined under equilibrium
conditions using a nonlinear BIA evaluation program. The
nonspecific binding control consisted of passing the analytes
on a free surface that had been previously activated and
blocked.
2.9. Humoral Response Evaluation by Line Print Immunoassay.
The protein EF-Tu and a set of antigens, purified protein
derivative of M. avium (PPDa), purified protein derivative
ofM. bovis (PPDb), and paratuberculosis protoplasmic anti-
gen (PPA3), were evaluated with different sera. Sera were
obtained from 10 healthy animals, from8 animalswith bovine
tuberculosis (TBB experimentally infected animals, positive
for delayed-type hypersensitivity—DTH—with PPDb and
with lesions at the end of the experience), and from 25
PTB naturally infected animals, positive for DTH with
PPDa and fecal culture positive. A total of 20𝜇L of each
of the antigens was applied onto a nitrocellulose mem-
brane (Amersham Hybond TM-ECL) using a semiautomatic
aerosolizer (Camag Scientific Inc., Wilmington, Delaware) at
a concentration of 100 𝜇g/mL. The membranes were blocked
and placed in a “mini blotter” (Isogen BioSolutions). This
procedure allowed simultaneous analysis of the 45 sera, which
were evaluated at dilutions of 1 : 100. After 1 h incubation,
sera were aspirated and the membranes were washed. The
membranes were then incubated with protein G conjugated
to peroxidase (1 : 1,500), washed, and finally developed with
chemiluminescence substrate (Pierce ECL Western blotting
substrate,Thermo Scientific) according to themanufacturer’s
directions.
3. Results
3.1. Analysis of MAP-Cell Wall Proteins. As a first screening
for surface-exposed immunogenic proteins, the MAP-cell
wall (CW) protein fraction was obtained and resolved by 2D-
SDS-PAGE and transferred onto a nitrocellulose membrane.
Then, the membranes were analyzed by Western blot using
a pool of sera from MAP-infected animals. The images were
digitalized and visually analyzed (Figure 1). A total of 41 spots
corresponding to proteins that were recognized by positive
sera were excised from a replicate Coomassie blue stained gel
and subsequently identified byMALDI-TOFMS. A total of 18
proteins were identified by this method (Table 1). We focused
our interest in proteins that were previously characterized
as adhesins in pathogenic microorganisms. Among these
proteins, we selected elongation factor Tu (EF-Tu) because
the homologous of Mycoplasma pneumoniae (identity 65%)
and Acinetobacter baumannii (identity 72%) functions as a
FN-binding protein that facilitates the interactions between
bacteria and extracellular matrix [30–32].
The eftu gene from MAP was evaluated for ortholo-
gous in M. avium strain 104 (GenBank accession number
NC 008595) and M. tuberculosis (Mtb) H37Rv (GenBank
accession number NC 000962). In the MAP genome (MAP
strain K-10 GenBank accession number NC 002944), this
gene was annotated as MAP 4143 and shares 93% of
nucleotide identity with that of Mtb and 100% with that of
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Figure 1: Analysis of MAP-cell wall proteins by 2D-SDS-PAGE. The cell wall protein fraction (CW) of MAP was resolved by 2D-SDS PAGE
per duplicate and the resulting gels were (a) stained with Coomassie blue or (b) transferred onto a nitrocellulose membrane and subjected to
Western blot. Sera from 5 positive animals were pooled and diluted to 1 : 100 to detect immunogenic proteins from the CW fraction.Molecular
weight standards are shown on the left.
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Figure 2: Purified EF-Tu protein using a ProBond Ni-NTA Resin column (Invitrogen). (a) Detection of the protein byWestern blot using an
anti-Histidine Antibody (Promega). (b) Coomassie blue stained gel showing the purified protein.
M. avium. The identity at the protein level is 100% between
MAP andM. avium and 97% with its orthologous in Mtb.
We searched for two FN-binding regions (FBR) in the
MAP-EF-Tu protein sequence, which has been previously
identified in the carboxyl terminus of Mycoplasma pneumo-
niae EF-Tu [32, 33]. The BlastP analysis is shown in Table 2.
The comparison of both regions yielded an identity of 73% for
FBR1 and 69% for FBR2.
3.2. Recombinant Expression and Ligand Blot Assay (LBA).
The MAP-EF-Tu protein was heterologously expressed in E.
coli as a recombinant His-tagged protein and its product
was purified under denaturing conditions. Purified EF-Tu
protein is showed in Figure 2. The purified protein was
used to perform LBA using FN as “bait.” Interactions were
detected with anti-FN polyclonal antiserum and an alkaline
phosphatase-conjugated antibody with further colorimetric
detection of the bound bait. A strong positive signal was
observed for EF-Tu and for Ag85 recombinant protein, which
was assayed as a positive control. No signal was observed for
the negative control, AhpC (Figure 3).
3.3. Dose-Response Curves. We further confirmed FN-EF-Tu
interactions using an ELISA assay with some modifications.
Plates were coated with 1 𝜇g of EF-Tu or AhpC used as a
negative control and then incubated with increasing concen-
trations of FN. After incubation with the hyperimmune anti-
FN serum followed by HRP-conjugated anti-mouse IgG and
the corresponding substrate, the absorbance was determined
in a microplate reader at 492 nm. We observed a dose-
dependent interaction confirming the binding of EF-Tu with
FN (Figure 4).
3.4. Surface Plasmon Resonance (SPR). To finally determine
the EF-Tu dissociation constant (KD), protein-protein inter-
actions were also assessed through SPR with a BIAcoreT100
system (GE Healthcare). FN was covalently immobilized
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Table 1: Immunogenic CW proteins of MAP identified by MALDI-TOF MS. Proteins were excised from Coomassie blue stained gels and
subsequently identified byMALDI-TOF at theMass Spectrometry Center for Biological and Chemical Analysis (CEQUIBIEM) at the School
of Exact and Natural Sciences, University of Buenos Aires. ND: no data.
Spot number MAP Locus Mtb Locus Gene Protein function/family ORF size (bp) Previously described asenvelope protein
1 MAP1164 Rv1436 gapdh
Glyceraldehyde-3-
phosphate
dehydrogenase
1,020 He and de Buck, 2010(MAP) [34]
2 MAP1205 Rv1479 moxR ATPase 1,143 Mawuenyega et al., 2005(Mtb) [35]
3 MAP1325 Rv1630 rpsA S1 30S ribosomal protein S1 1,443 Gu et al., 2003 (Mtb) [36]
4 MAP1367 Rv1658 argG Argininosuccinate synthase 1,197 ND
5 MAP1889c Rv2145c wag31 DivIVA family protein 783 He and de Buck, 2010(MAP) [34]
6 MAP1962 Rv2220 glnA1 Glutamine synthetase A1 1,437 Gu et al., 2003 (MAP) [36]
7 MAP1998 Rv2245 kasA 3-Oxoacyl synthetase 1,251 He and de Buck, 2010(MAP) [34]
8 MAP1999 Rv2246 kasB 1 3-Oxoacyl sintase 2 B 1,323 Mawuenyega et al., 2005(Mtb) [35]
9 MAP2453c Rv1308 atpA ATP synthase subunit alpha 1,665 He and de Buck, 2010(MAP) [34]
10 MAP2855c Rv2744c 35kd ag Phage shock protein A 828 ND
5 MAP3152c Rv3075c hpcH/hpaI Aldolase/citrate lyase 921 Gu et al., 2003 (MAP) [36]
11 MAP3404 Rv3285 accA3 Carbamoyl-phosphatesynthase subunit A 1,824
Mawuenyega et al., 2005
(Mtb) [35]
12 MAP3567 Rv0148 Hypothetical protein Short-chaindehydrogenases/reductases 864
He and de Buck, 2010
(MAP) [34]
13 MAP3651c Rv0215c fadE3 2 Acyl-CoA dehydrogenaseFadE3 1,218
He and de Buck, 2010
(MAP) [34]
7 MAP3692c Rv0242c fabG4 3-Ketoacyl reductase 1,365 He and de Buck, 2010(MAP) [34]
14 MAP3853 Rv0384c clpB ATP dependent proteaseClpB 2,547
He and de Buck, 2010
(MAP) [34]
3 MAP3936 Rv0440 groEL2 GroEL chaperonin 1,626 He and de Buck, 2010(MAP) [34]
15 MAP4143 Rv0685 eftu Elongation factor Tu 1,191 He and de Buck, 2010(MAP) [34]
Table 2: BlastP comparison between the two fibronectin binding
regions (FBRs) of EF-Tu identified by Balasubramanian and collab-
orators [37] inMycoplasma pneumoniae (MP) and the homologous
regions in MAP.
MP amino
acid region
MAP amino
acid region
Identity
between MP
and MAP (%)
FBR1 192–219 193–220 73
FBR2 340–358 342–360 69
on the BIAcore CM-5 sensor chip. Solutions of EF-Tu at
different concentrations were injected over immobilized FN.
The obtained KD was within the 𝜇M order, (3.1 ± 0.9) 10−6M
(Figure 5).This value is similar to the values of other adhesins
previously described [38]. The control using denaturized EF-
Tu was not able to bind FN. Therefore, all these experiments
confirmed the FN/EF-Tu binding with a moderate affinity
through conformational sites.
3.5. Humoral Response Evaluation by Line Print Immunoassay.
FN-binding proteins could play a role in adhesion to the host
and immunomodulation. With this in mind, we analyzed
whether EF-Tu is able to stimulate antibody production.
Using a line print assay, we evaluated a broader set of sera
including TBB-infected animals and negative controls. The
sera were obtained from 25 MAP-naturally infected cattle,
8 M. bovis-experimentally infected cattle, and 10 healthy
bovines (negative controls). EF-Tu was recognized by 64%
of the MAP positive sera. However, this protein was also
recognized by sera of healthy and TBB animals, suggest-
ing the presence of antigenic epitopes conserved among
mycobacteria species, including environmentalmycobacteria
that sensitizes healthy cattle (Table 3).
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Figure 3: Analysis of FN-binding capability of EF-Tu through a
LBA. The blot with the recombinant proteins was incubated with
20 𝜇g/mL FN. Colorimetric detection of the bound bait protein was
performed. We observed positive signal indicating the FN-binding
capability of EF-Tu and the positive control Ag85 (red circles). AhpC
was used as a negative control.
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Figure 4: Dose-response curves assayed by ELISA. Plates were
coated with EF-Tu (black bars) or AhpC (white bars) used as
negative control and incubated with different concentrations of FN.
The absorbance, measured at 492 nm, showed a dose-dependent
interaction confirming the binding of EF-Tu with FN. Significantly
different from values of the control protein AhpC ∗∗𝑃 < 0.01,
∗
𝑃 < 0.05.
4. Discussion
MAP invades the intestinal tissue primarily through M cells.
This could occur through FN-dependent mechanisms that
involve the binding of FN to proteins of the MAP CW
and to integrin receptors present on the luminal surface of
M cells. 𝛽1 integrins have been identified as the host cell
receptors. In addition, the attachment and internalization of
MAP by epithelial cells in vitro and in vivo depend on APA-
FN interactions [4]. However, other MAP proteins could be
involved in FN binding and they could be important for host-
pathogen interactions.
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Figure 5: KD determination by surface plasmon resonance. Protein
solutions of EF-Tu at different concentrations were injected over
immobilized FN.Theexperiment confirmedFN-EFTubinding,with
a KD of (3.1 ± 0.9) 10−6M.
Table 3: Reactivity of bovine sera to the protein EF-Tu by line print
immunoassay. 20 𝜇L of antigens was applied onto a nitrocellulose
membrane and simultaneously confronted to sera from 10 healthy
animals, 8 animals with bovine tuberculosis (TBB), and 25 animals
with paratuberculosis (PTB). Sixty four percent ofMAPpositive sera
recognized EF-Tu.
Number of sera with positive recognition
Antigen Healthy(𝑛 = 10)
PTB infected
(𝑛 = 25)
TBB infected
(𝑛 = 8)
PPDA 4 16 3
PPA-3 1 18 2
PPDB 6 1 4
EF-Tu 8 16 7
In this study, we have identified immunogenic CW
proteins of MAP by 2D and MALDI-TOFMS analysis. From
the identified proteins, we selected one candidate based on
the similarity with other proteins having the ability to bind
ECM molecules in other pathogenic bacteria: elongation
factor Tu (EF-Tu).
We first screened its FN-binding capability through a
ligand blot assay using FN and anti-FN antibodies. This
screening confirmed that, in these conditions, EF-Tu binds
FN (Figure 3). Through ELISA assays, using increasing con-
centrations of FN, we confirmed the interaction in a dose-
dependent manner (Figure 4). We finally determine the
dissociation constantKDby SPR analysis, which yielded aKD
within the order of 𝜇M (Figure 5) consistent with previous
reports [38].
Several Mycobacterium adhesins capable to bind ECM
proteins have been identified inmycobacteria, such as antigen
85 complex [11–15], APA [19–23], and GlnA1 [26]. Several
reports have demonstrated that these proteins are involved
in bacterial dissemination. EF-Tu is a protein responsible
for critical steps in protein synthesis [39]. Moreover, this
protein is a cytoplasmic protein with unusual CW location
among microorganisms. For instance, when E. coli is starved
for carbohydrates, nitrogen, and phosphate, this protein
becomes methylated and associates to the membrane [40]. In
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addition, this protein was detected as a major CW protein
of Mycobacterium leprae [41]. On the other hand, EF-Tu
has been identified with periplasmic location in Neisseria
gonorrhoeae [42] and in E. coli [43]. In Lactobacillus johnsonii
and Listeria monocytogenes, EF-Tu is also associated to the
membrane; in these bacteria this protein mediates binding to
mucin [44] and fibrinogen [37], respectively. Recently, it has
been reported that EF-Tu binds factor H and plasminogen
in Pseudomonas aeruginosa [45]. Thus, EF-Tu joins the
group of housekeeping enzymes, which includes enolase
[46], glyceraldehyde-3-phosphate dehydrogenase [47], and
pyruvate dehydrogenase [30], that exhibit unexpected bio-
logical functions in addition to their well-defined enzymatic
activities. Despite the classification of EF-Tu as a cytosolic
protein, Balasubramanian and collaborators [32] have shown
that EF-Tu can relocate to the mycoplasma membrane sur-
face with an exposed carboxyl terminus that facilitates FN
binding. On the other hand, other reports document the
presence of cytosolic proteins, including EF-Tu, on surfaces of
different bacteria. Important questions regarding how these
proteins translocate to the surface remain unanswered, espe-
cially since conventional secretion or anchoring signals are
absent. The cytoplasmic enzymefructose-1, 6-bisphosphate
aldolase (FBA) has also been found on the surface of several
pathogenic bacteria. FBA is a glycolytic enzymethat, despite
lacking secretion signals, translocates across the different
compartments of the bacterial cell to access the surface, where
it binds host molecules and exhibits nonglycolytic functions
[40, 41].
The interaction of EF-Tu with the ECM could be a
keymechanism during host-pathogen interactions, However,
the overall contribution of this adhesin to the host cell
binding remains unclear. Although there is a dose-dependent
specific binding of EF-Tu to immobilized FN, the affinity
of EF-Tu to FN is intermediate. In the present study, EF-Tu
displayed a KD in the 𝜇M range, similar to other proteins
proposed as adhesins. For instance, a surface-exposed protein
of leptospira, Lsa20, binds to plasminogen and laminin
with a KD in the 𝜇M range, postulated as a protein with
adherence function and proteolytic activity [38]. Moreover,
these adhesins can also bind other proteins of the ECM, such
as elastin, laminin, and plasminogen, which contributes to
adhesion, to invasion, and to the virulence of the bacteria
modulating the immune response [15, 24, 45].
In our study, recombinant EF-Tu was recognized by 64%
of sera fromMAP-infected cattle, suggesting a putative role in
the host immune response. However, sera from noninfected
animals also recognize EF-Tu. This result could be due to the
presence of EF-Tu in environmental mycobacteria, such as
M. avium, which shares 100% identity with the MAP protein.
Moreover, the suggested role of EF-Tu in the virulence of
pathogenic bacteria could be related to the host-pathogen
interactions.
Kuo and collaborators [15] demonstrated that reducing
the expression of FN on Caco-2 cells that were transfected
with FN-siRNA impaired the ability of Ag85 or Ag85-
expressing MAP K-10 to bind to the Caco-2 cells. How-
ever, MAP K-10 strain binding to FN siRNA-transfected
Caco-2 cells showed only a 9.7% reduction (compared with
the negative siRNA transfection). This finding suggests that
FN is not the only bacterial adhesion ligand contributing to
the MAP ability to bind to host cells. Additionally, the MAP
Ag85 interaction to FN only partially accounted for MAP’s
ability to bind host cells. Other surface antigens of MAP K-10
probably participate in additional ECM interactions.
In conclusion, we have identified a novel FN-binding
MAP protein, EF-Tu, that could be implicated in the entrance
of MAP into the epithelial cells, which is the first step of
mycobacteria infection necessary for the progression of PTB.
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